The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction

M. Henkens, S. Remmelzwaal, A. J. Van Ballegooijen, E. Robbinson, A. Barandiaran Aizpurua, A. G. Raafs, J. A. J. Verdonschot, M. R. Hazebroek, S. Van Sanders-Wijk, V. P. M. Van Empel, R. Vos, H. P. Brunner-La Rocca, J. W. J. Beulens, S. R. B. Heymans

Research output: Contribution to journal › Meeting Abstract › Academic

Original languageEnglish
Pages (from-to)21-21
JournalEuropean Journal of Heart Failure
Volume21
Publication statusPublished - May 2019

Cite this

Henkens, M. ; Remmelzwaal, S. ; Van Ballegooijen, A. J. ; Robbinson, E. ; Aizpurua, A. Barandiaran ; Raafs, A. G. ; Verdonschot, J. A. J. ; Hazebroek, M. R. ; Van Sanders-Wijk, S. ; Van Empel, V. P. M. ; Vos, R. ; Rocca, H. P. Brunner-La ; Beulens, J. W. J. ; Heymans, S. R. B. / The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction. In: European Journal of Heart Failure. 2019 ; Vol. 21. pp. 21-21.
@article{d71ebec83c0742b58d391a309627c4c5,
title = "The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction",
author = "M. Henkens and S. Remmelzwaal and {Van Ballegooijen}, {A. J.} and E. Robbinson and Aizpurua, {A. Barandiaran} and Raafs, {A. G.} and Verdonschot, {J. A. J.} and Hazebroek, {M. R.} and {Van Sanders-Wijk}, S. and {Van Empel}, {V. P. M.} and R. Vos and Rocca, {H. P. Brunner-La} and Beulens, {J. W. J.} and Heymans, {S. R. B.}",
year = "2019",
month = "5",
language = "English",
volume = "21",
pages = "21--21",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "Wiley-Blackwell",

}

Henkens, M, Remmelzwaal, S, Van Ballegooijen, AJ, Robbinson, E, Aizpurua, AB, Raafs, AG, Verdonschot, JAJ, Hazebroek, MR, Van Sanders-Wijk, S, Van Empel, VPM, Vos, R, Rocca, HPB-L, Beulens, JWJ & Heymans, SRB 2019, 'The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction' European Journal of Heart Failure, vol. 21, pp. 21-21.

The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction. / Henkens, M.; Remmelzwaal, S.; Van Ballegooijen, A. J.; Robbinson, E.; Aizpurua, A. Barandiaran; Raafs, A. G.; Verdonschot, J. A. J.; Hazebroek, M. R.; Van Sanders-Wijk, S.; Van Empel, V. P. M.; Vos, R.; Rocca, H. P. Brunner-La; Beulens, J. W. J.; Heymans, S. R. B.

In: European Journal of Heart Failure, Vol. 21, 05.2019, p. 21-21.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction

AU - Henkens, M.

AU - Remmelzwaal, S.

AU - Van Ballegooijen, A. J.

AU - Robbinson, E.

AU - Aizpurua, A. Barandiaran

AU - Raafs, A. G.

AU - Verdonschot, J. A. J.

AU - Hazebroek, M. R.

AU - Van Sanders-Wijk, S.

AU - Van Empel, V. P. M.

AU - Vos, R.

AU - Rocca, H. P. Brunner-La

AU - Beulens, J. W. J.

AU - Heymans, S. R. B.

PY - 2019/5

Y1 - 2019/5

M3 - Meeting Abstract

VL - 21

SP - 21

EP - 21

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

ER -

Henkens M, Remmelzwaal S, Van Ballegooijen AJ, Robbinson E, Aizpurua AB, Raafs AG et al. The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction. European Journal of Heart Failure. 2019 May;21:21-21.